nodes	percent_of_prediction	percent_of_DWPC	metapath
Levonordefrin—Isoetarine—ADRB1—dilated cardiomyopathy	0.0165	0.106	CrCbGaD
Levonordefrin—Isoetarine—ADRB2—dilated cardiomyopathy	0.0139	0.0894	CrCbGaD
Levonordefrin—Salbutamol—ADRB1—dilated cardiomyopathy	0.0128	0.0821	CrCbGaD
Levonordefrin—Salbutamol—ADRB2—dilated cardiomyopathy	0.0107	0.069	CrCbGaD
Levonordefrin—Norepinephrine—SLC22A5—dilated cardiomyopathy	0.00921	0.0592	CrCbGaD
Levonordefrin—Dopamine—SLC22A5—dilated cardiomyopathy	0.00857	0.055	CrCbGaD
Levonordefrin—Epinephrine—SLC22A5—dilated cardiomyopathy	0.00836	0.0537	CrCbGaD
Levonordefrin—Phenylpropanolamine—ADRB1—dilated cardiomyopathy	0.00823	0.0529	CrCbGaD
Levonordefrin—Droxidopa—ADRB1—dilated cardiomyopathy	0.00756	0.0486	CrCbGaD
Levonordefrin—Phenylpropanolamine—ADRB2—dilated cardiomyopathy	0.00692	0.0445	CrCbGaD
Levonordefrin—Isoprenaline—ADRB1—dilated cardiomyopathy	0.00687	0.0442	CrCbGaD
Levonordefrin—Norepinephrine—ADRB1—dilated cardiomyopathy	0.00636	0.0409	CrCbGaD
Levonordefrin—Droxidopa—ADRB2—dilated cardiomyopathy	0.00636	0.0408	CrCbGaD
Levonordefrin—Dopamine—ADRB1—dilated cardiomyopathy	0.00592	0.038	CrCbGaD
Levonordefrin—Isoprenaline—ADRB2—dilated cardiomyopathy	0.00578	0.0371	CrCbGaD
Levonordefrin—Epinephrine—ADRB1—dilated cardiomyopathy	0.00577	0.0371	CrCbGaD
Levonordefrin—Epinephrine—TNF—dilated cardiomyopathy	0.00548	0.0352	CrCbGaD
Levonordefrin—Norepinephrine—ADRB2—dilated cardiomyopathy	0.00535	0.0344	CrCbGaD
Levonordefrin—Epinephrine—ADRB2—dilated cardiomyopathy	0.00486	0.0312	CrCbGaD
Levonordefrin—ADRA1A—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.00268	0.00318	CbGpPWpGaD
Levonordefrin—ADRA2C—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00267	0.00316	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00266	0.00315	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00265	0.00314	CbGpPWpGaD
Levonordefrin—ADRA1A—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.00263	0.00312	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00257	0.00304	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—ACTN2—dilated cardiomyopathy	0.00256	0.00304	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00247	0.00293	CbGpPWpGaD
Levonordefrin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00244	0.00289	CbGpPWpGaD
Levonordefrin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00244	0.00289	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—TTN—dilated cardiomyopathy	0.0024	0.00284	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.0024	0.00284	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—VCL—dilated cardiomyopathy	0.00233	0.00276	CbGpPWpGaD
Levonordefrin—ADRA2A—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00233	0.00276	CbGpPWpGaD
Levonordefrin—ADRA2A—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00233	0.00276	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00233	0.00276	CbGpPWpGaD
Levonordefrin—ADRA1A—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.00231	0.00274	CbGpPWpGaD
Levonordefrin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00228	0.0027	CbGpPWpGaD
Levonordefrin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00228	0.0027	CbGpPWpGaD
Levonordefrin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00227	0.00269	CbGpPWpGaD
Levonordefrin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.0022	0.0026	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00219	0.00259	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—VCL—dilated cardiomyopathy	0.00218	0.00258	CbGpPWpGaD
Levonordefrin—ADRA2A—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00217	0.00256	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00216	0.00256	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00216	0.00256	CbGpPWpGaD
Levonordefrin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00212	0.00251	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00209	0.00248	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—ACTN2—dilated cardiomyopathy	0.00208	0.00247	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00208	0.00246	CbGpPWpGaD
Levonordefrin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.00207	0.00245	CbGpPWpGaD
Levonordefrin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00205	0.00243	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00205	0.00242	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00201	0.00238	CbGpPWpGaD
Levonordefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00199	0.00236	CbGpPWpGaD
Levonordefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00199	0.00236	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00195	0.00231	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00194	0.0023	CbGpPWpGaD
Levonordefrin—ADRA2B—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.00194	0.0023	CbGpPWpGaD
Levonordefrin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00188	0.00222	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00186	0.0022	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00186	0.0022	CbGpPWpGaD
Levonordefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00185	0.00219	CbGpPWpGaD
Levonordefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00185	0.00219	CbGpPWpGaD
Levonordefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00185	0.00219	CbGpPWpGaD
Levonordefrin—ADRA2B—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.00183	0.00216	CbGpPWpGaD
Levonordefrin—ADRA2C—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.00181	0.00214	CbGpPWpGaD
Levonordefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00179	0.00213	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00179	0.00212	CbGpPWpGaD
Levonordefrin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00178	0.00211	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—VCL—dilated cardiomyopathy	0.00177	0.0021	CbGpPWpGaD
Levonordefrin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00175	0.00208	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00174	0.00206	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00174	0.00206	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00173	0.00205	CbGpPWpGaD
Levonordefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00172	0.00204	CbGpPWpGaD
Levonordefrin—ADRA2C—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.00171	0.00202	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.0017	0.00201	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—ANKRD1—dilated cardiomyopathy	0.00168	0.00199	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00167	0.00198	CbGpPWpGaD
Levonordefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00167	0.00198	CbGpPWpGaD
Levonordefrin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00166	0.00197	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00166	0.00197	CbGpPWpGaD
Levonordefrin—ADRA2B—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00166	0.00197	CbGpPWpGaD
Levonordefrin—ADRA1A—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.00163	0.00193	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00161	0.00191	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—TAZ—dilated cardiomyopathy	0.00158	0.00187	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00158	0.00187	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00156	0.00185	CbGpPWpGaD
Levonordefrin—ADRA2C—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00155	0.00184	CbGpPWpGaD
Levonordefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00153	0.00182	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00152	0.0018	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00152	0.0018	CbGpPWpGaD
Levonordefrin—ADRA2A—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.00147	0.00174	CbGpPWpGaD
Levonordefrin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.00146	0.00173	CbGpPWpGaD
Levonordefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00145	0.00172	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—SDHA—dilated cardiomyopathy	0.00143	0.00169	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00143	0.00169	CbGpPWpGaD
Levonordefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00142	0.00169	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00141	0.00167	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00141	0.00167	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00141	0.00167	CbGpPWpGaD
Levonordefrin—ADRA2A—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.00139	0.00164	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00137	0.00162	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—ANKRD1—dilated cardiomyopathy	0.00137	0.00162	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00136	0.00161	CbGpPWpGaD
Levonordefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00135	0.0016	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00134	0.00158	CbGpPWpGaD
Levonordefrin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00132	0.00156	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00131	0.00155	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—TAZ—dilated cardiomyopathy	0.00128	0.00152	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00127	0.0015	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00127	0.0015	CbGpPWpGaD
Levonordefrin—ADRA2A—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00126	0.00149	CbGpPWpGaD
Levonordefrin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00123	0.00146	CbGpPWpGaD
Levonordefrin—ADRA2B—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.00121	0.00143	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—ITGB1—dilated cardiomyopathy	0.00117	0.00139	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00117	0.00138	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—SDHA—dilated cardiomyopathy	0.00116	0.00138	CbGpPWpGaD
Levonordefrin—ADRA2C—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.00113	0.00134	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00111	0.00131	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—ITGB1—dilated cardiomyopathy	0.00109	0.0013	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00108	0.00128	CbGpPWpGaD
Levonordefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00108	0.00128	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00105	0.00124	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00105	0.00124	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00103	0.00122	CbGpPWpGaD
Levonordefrin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.00101	0.0012	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00101	0.00119	CbGpPWpGaD
Levonordefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.001	0.00119	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—CD36—dilated cardiomyopathy	0.000999	0.00118	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000981	0.00116	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000981	0.00116	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000977	0.00116	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000954	0.00113	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000954	0.00113	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000946	0.00112	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—RAC1—dilated cardiomyopathy	0.000941	0.00111	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00094	0.00111	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—CD36—dilated cardiomyopathy	0.000933	0.00111	CbGpPWpGaD
Levonordefrin—ADRA2A—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.000919	0.00109	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000912	0.00108	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000891	0.00106	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000891	0.00106	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—ITGB1—dilated cardiomyopathy	0.000889	0.00105	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000887	0.00105	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000884	0.00105	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—RAC1—dilated cardiomyopathy	0.000879	0.00104	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000859	0.00102	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000858	0.00102	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000858	0.00102	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000828	0.000981	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000821	0.000973	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000808	0.000957	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000802	0.00095	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000798	0.000945	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000797	0.000944	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000797	0.000944	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000779	0.000923	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000779	0.000923	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000772	0.000915	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000766	0.000908	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000763	0.000904	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—CD36—dilated cardiomyopathy	0.000758	0.000898	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000755	0.000894	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000741	0.000878	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000734	0.000869	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000724	0.000858	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000724	0.000857	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000724	0.000857	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000718	0.00085	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000716	0.000848	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—RAC1—dilated cardiomyopathy	0.000714	0.000846	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000701	0.000831	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000696	0.000824	CbGpPWpGaD
Levonordefrin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000693	0.000821	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000685	0.000812	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000673	0.000797	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00066	0.000781	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000652	0.000772	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00065	0.00077	CbGpPWpGaD
Levonordefrin—SLC6A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000644	0.000763	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000635	0.000752	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000626	0.000741	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—RAF1—dilated cardiomyopathy	0.000624	0.000739	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000613	0.000726	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000599	0.000709	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000595	0.000705	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000593	0.000702	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—RAF1—dilated cardiomyopathy	0.000583	0.000691	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000581	0.000689	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000568	0.000673	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000568	0.000673	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000564	0.000667	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000564	0.000667	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000557	0.000659	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000556	0.000658	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.00054	0.00064	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000531	0.000629	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000528	0.000625	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000526	0.000623	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000526	0.000623	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000524	0.00062	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000518	0.000614	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000516	0.000611	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000507	0.000601	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000505	0.000598	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000489	0.00058	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000486	0.000575	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000482	0.000571	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000482	0.00057	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000474	0.000561	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—RAF1—dilated cardiomyopathy	0.000474	0.000561	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000464	0.00055	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.00046	0.000545	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.00046	0.000545	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000451	0.000535	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000441	0.000523	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000433	0.000513	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000431	0.000511	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000428	0.000507	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000428	0.000506	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000428	0.000506	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000422	0.000499	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000414	0.000491	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000411	0.000487	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.00041	0.000485	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000405	0.000479	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000398	0.000471	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000392	0.000464	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—GPX1—dilated cardiomyopathy	0.000388	0.00046	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000385	0.000456	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000384	0.000455	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—CD36—dilated cardiomyopathy	0.000378	0.000448	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000358	0.000424	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000354	0.000419	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000353	0.000418	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—AGT—dilated cardiomyopathy	0.000341	0.000403	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000336	0.000398	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000335	0.000396	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.00033	0.000391	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000329	0.000389	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000319	0.000378	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—GPX1—dilated cardiomyopathy	0.000316	0.000374	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000312	0.000369	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—CD36—dilated cardiomyopathy	0.000307	0.000364	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—AGT—dilated cardiomyopathy	0.000305	0.000361	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000298	0.000353	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000293	0.000346	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000288	0.000342	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—AGT—dilated cardiomyopathy	0.000285	0.000337	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—AGT—dilated cardiomyopathy	0.000277	0.000328	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000272	0.000322	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000268	0.000317	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000261	0.000309	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—AGT—dilated cardiomyopathy	0.000249	0.000295	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000246	0.000291	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000242	0.000287	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—AGT—dilated cardiomyopathy	0.000231	0.000274	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000229	0.000272	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000212	0.000251	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000201	0.000238	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000198	0.000234	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000186	0.000221	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000173	0.000205	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000161	0.00019	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000145	0.000172	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000136	0.000161	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000119	0.00014	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—EGFR—dilated cardiomyopathy	0.00011	0.00013	CbGpPWpGaD
